Source: Annual Congress 2003 - Management of COPD in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Rascati, R. Stanford, R. Borker (Austin, Raleigh, United States Of America). Comparison of hospitalization risk for Medicaid patients with COPD by medication regimen. Eur Respir J 2003; 22: Suppl. 45, 2432

Member's Comments

No comment yet.

Related content which might interest you: Impact of home hospitalization on treatment compliance in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 207s Year: 2001 Preventative care and home treatment in patients at risk of hospitalisation due to exacerbation of COPD. Source: International Congress 2018 – The many facets of respiratory nursing Year: 2018 Predictors of mortality in COPD patients after hospitalization due to an exacerbation Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Potential use of a COPD ²e-passport² for assessing hospitalization risks during outpatient visits Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Exacerbation types by COPD severity; risk of hospitalisation by patients not seeking treatment Source: Eur Respir J 2003; 22: Suppl. 45, 353s Year: 2003 Cost burden in COPD patients initiating ICS vs. non-ICS maintenance regimens Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019 β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Effect of daily azithromycin therapy and adherence on readmission risk in COPD Source: Eur Respir J, 53 (3) 1801377; 10.1183/13993003.01377-2018 Year: 2019 Evaluation of costs of inhospital treatment of COPD exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 64s Year: 2004 Do cardiovascular drugs reduce exacerbations rates in primary care patients with COPD? Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007 Compliance of COPD patients to their treatment Source: Eur Respir J 2003; 22: Suppl. 45, 244s Year: 2003 Predictors of exacerbations requiring hospitalisation in patients with stable COPD Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006 Risk factors for hospitalisation of CAP patients initially treated in an outpatient setting Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Hospitalisation of COPD patients due to comorbidity Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 Impact of definition when assessing the cumulative incidence of exacerbation amongst a cohort of primary care COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004 Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD Source: Annual Congress 2012 - COPD: risk factors, biomarkers and diagnosis Year: 2012 Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Rehospitalization rates for patients with COPD who require supplemental oxygen therapy following a hospitalization for an exacerbation Source: Annual Congress 2012 - The latest insights in integrated care Year: 2012 Trends in the lifetime risk of COPD exacerbation requiring hospitalisation Source: Eur Respir J 2013; 42: 964-971 Year: 2013 Six months azithromycin treatment in COPD patients with high risk of further exacerbations Source: International Congress 2017 – Management of COPD Year: 2017